Active, not recruitingNCT05079334
Family History and Cancer Risk Study
Studying Congenital Malformation Syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vanderbilt University Medical Center
- Principal Investigator
- Georgia Wiesner, MDVanderbilt University Medical Center
- Enrollment
- 1847 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2026
Study locations (2)
- Meharry Medical College, Nashville, Tennessee, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05079334 on ClinicalTrials.govOther trials for Congenital Malformation Syndrome
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07511660Intra Ovarian Muse Cell Injection for Perimenopause Symptom Relief and Ovarian Function Restoration (MUSE-OVARY)Healing Hope International
- RECRUITINGNANCT06909656Multimodal Electrophysiological Study of Cortico-subcortical Biomarkers of Tics in Tourette SyndromeUniversity Hospital, Bordeaux